Blog

Researchers at Wake Forest University report that, in some cases, quality of life improves for those who undergo cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with peritoneal mesothelioma. The surgery and corresponding chemotherapy have become an accepted treatment for this type of cancer which affects the lining of the abdominal cavity (peritoneum). Peritoneal

A family whose loved one receives a mesothelioma diagnosis suffers immense emotional trauma. The disease is deadly, and victims often do not live for more than a year. While much has been written about the emotional toll this condition takes on those it impacts, less has been said about the medical costs associated with the

International researchers are using molecular profiling to identify different types of pleural mesothelioma tumors, according to an October 2019 study. These profiles allow doctors to distinguish tumors that otherwise look very similar under a microscope, which is essential to making a correct diagnosis and administering the most effective treatments. New Findings May Help Malignant Pleural

Photo Credit: 2019 Novocure. All rights reserved. The U.S. Food & Drug Administration (FDA) recently approved a breakthrough treatment option for malignant pleural mesothelioma patients. Novocure’s NovoTTF-100L offers new hope, with clinical trials improving the prognosis of patients who used it with chemotherapy. It is the first new treatment option for the deadly disease to

At a recent International Symposium on Malignant Mesothelioma, three doctors representing some of the biggest organizations behind mesothelioma treatment discussed what patients should look for to determine a truly outstanding mesothelioma treatment center. The quality of the center you choose for your care may determine your treatment options, your prognosis, and overall, your quality of